Abstract:Alteration of the lung microbiome has been observed in several respiratory tract diseases. However, most previous studies were based on 16S ribosomal RNA and shotgun metagenome sequencing; the viability and functional activity of the microbiome, as well as its interaction with host immune systems, have not been well studied. To characterize the active lung microbiome and its associations with host immune response and clinical features, we applied metatranscriptome sequencing to bronchoalveolar lavage fluid (BALF) samples from 25 patients with chronic obstructive pulmonary disease (COPD) and from nine control cases without known pulmonary disease. Community structure analyses revealed three distinct microbial compositions, which were significantly correlated with bacterial biomass, human Th17 immune response, and COPD exacerbation frequency. Specifically, samples with transcriptionally active Streptococcus, Rothia, or Pseudomonas had bacterial loads 16 times higher than samples enriched for Escherichia and Ralstonia. These high-bacterial-load samples also tended to undergo a stronger Th17 immune response. Furthermore, an increased proportion of lymphocytes was found in samples with active Pseudomonas. In addition, COPD patients with active Streptococcus or Rothia infections tended to have lower rates of exacerbations than patients with active Pseudomonas and patients with lower bacterial biomass. Our results support the idea of a stratified structure of the active lung microbiome and a significant host-microbe interaction. We speculate that diverse lung microbiomes exist in the population and that their presence and activities could either influence or reflect different aspects of lung health.IMPORTANCE Recent studies of the microbiome proposed that resident microbes play a beneficial role in maintaining human health. Although lower respiratory tract disease is a leading cause of sickness and mortality, how the lung microbiome interacts with human health remains largely unknown. Here we assessed the association between the lung microbiome and host gene expression, cytokine concentration, and over 20 clinical features. Intriguingly, we found a stratified structure of the active lung microbiome which was significantly associated with bacterial biomass, lymphocyte proportion, human Th17 immune response, and COPD exacerbation frequency. These observations suggest that the microbiome plays a significant role in lung homeostasis. Not only microbial composition but also active functional elements and host immunity characteristics differed among different individuals. Such diversity may partially account for the variation in susceptibility to particular diseases.

Tobacco use, self-reported professional dental cleaning habits, and lung adenocarcinoma diagnosis are associated with bronchial and lung microbiome alpha diversity

From tobacco smoking to mutational signature: the role of epigenetic changes in human cancers

Transcriptionally Active Lung Microbiome And Its Association With Bacterial Biomass And Host Inflammatory Status

Variation in Oral Microbiome is Associated with Future Risk of Lung Cancer among Never-Smokers

Role of Respiratory System Microbiota in Development of Lung Cancer and Clinical Application

The respiratory tract microbiome and its relationship to lung cancer and environmental exposures found in rural China.

Association Of Oral Microbiota And Periodontal Disease With Lung Cancer: A Systematic Review And Meta-Analysis

From Tobacco Smoking to Cancer Mutational Signature: a Mediation Analysis Strategy to Explore the Role of Epigenetic Changes

Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer

The Microbiome of Lower Respiratory Tract and Tumor Tissue in Lung Cancer Manifested As Radiological Ground-Glass Opacity

Association of oral microbiota with lung cancer risk in a low-income population in the Southeastern USA

Association Studies on Gut and Lung Microbiomes in Patients with Lung Adenocarcinoma

Convergent alteration of lung tissue microbiota and tumor cells in lung cancer

Interaction between the microbiome and TP53 in human lung cancer

146P A New Biomarker of Microbe: Akkermansia Muciniphila in Lung Adenocarcinoma Tissues May Predict Lymph Node Metastasis in Lung Adenocarcinoma

Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis

Association of Cigarette Smoking with Oral Bacterial Microbiota and Cardiometabolic Health in Chinese Adults

The Potential Role of Lung Microbiota in Lung Cancer Attributed to Household Coal Burning Exposures

Peripheral blood microbial signatures in current and former smokers

Smoking and microbiome in oral, airway, gut and some systemic diseases

Exploring the lung microbiome's role in disease